|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Buildings and equipment | |||||||||
| Less: accumulated depreciation | |||||||||
| Land | |||||||||
| Developments | |||||||||
| Net investment in real estate | |||||||||
| Assets held for sale | |||||||||
| Investments in unconsolidated ventures | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Accounts receivable, net | |||||||||
| Deferred expenses, net | |||||||||
| Operating lease right-of-use assets, net | |||||||||
| Other assets, net | |||||||||
| Total assets | |||||||||
| LIABILITIES | |||||||||
| Mortgages payable, net | |||||||||
| Mortgages payable related to assets held for sale | |||||||||
| Operating lease obligations | |||||||||
| Accounts payable and other liabilities | |||||||||
| Total liabilities | |||||||||
| EQUITY | |||||||||
| Common stock, $0.01 par value, 480,000 shares authorized, 12,805 issued and outstanding as of June 30, 2026 and 12,777 issued and outstanding as of December 31, 2025 | |||||||||
| Additional paid in capital | |||||||||
| Accumulated deficit | |||||||||
| Net parent investment | |||||||||
| Total stockholders' equity | |||||||||
| Noncontrolling interest in subsidiary | |||||||||
| Total equity | |||||||||
| Total liabilities and equity |
Loading...
